Hematology NewsPediatrician with SCD gives her young patients hopeSeptember 27, 2023Bleeding DisordersAnemiaSickle Cell Disease
Hematology NewsNationwide hematologists shortage: What’s being done?September 20, 2023Bleeding DisordersBusiness of MedicineMixed TopicsThrombosis
Hematology NewsUsing JAK inhibitors for myelofibrosisSeptember 11, 2023Myelodysplastic SyndromeAMLAnemiaBleeding DisordersMixed TopicsThrombosisTransfusion Medicine
Hematology NewsCHP/CCUS: Low blood cancer risk for most patientsSeptember 8, 2023Mixed TopicsMyelodysplastic SyndromeAnemiaThrombosisPatient & Survivor CareBleeding Disorders
Hematology NewsHemophilia: Concizumab lessens bleeding, could expand treatment optionsAugust 31, 2023Bleeding Disorders
Hematology NewsSCD: Survival disparities seen across insurance typesAugust 21, 2023Bleeding Disorders
Hematology NewsSCD, beta-thalassemia: CRISPR-based gene therapy `transformative’July 10, 2023Mixed TopicsBleeding DisordersCellular Therapy
Hematology NewsGuide explains nonsurgical management of major hemorrhageJune 8, 2023Bleeding DisordersTransfusion Medicine
Hematology NewsFocus of new ASH VTE guidelines: Thrombophilia testingMay 23, 2023Bleeding DisordersThrombosisMixed Topics
Hematology NewsRed-cell donor’s sex does not affect transfusion survivalApril 18, 2023TransplantBleeding DisordersMyelodysplastic Syndrome
Hematology NewsHemophilia A gene therapy under FDA reviewFebruary 27, 2023Bleeding DisordersGene Therapy
Hematology NewsEfanesoctocog alfa treatment: ‘Victory’ over hemophilia AFebruary 27, 2023Bleeding Disorders
Hematology NewsEurope approves first gene therapy for hemophilia BFebruary 27, 2023Bleeding DisordersGene Therapy
